PMID: 1204278Dec 1, 1975Paper

Clinical pharmacology of nabilone, a cannabinol derivative

Clinical Pharmacology and Therapeutics
L Lemberger, H Rowe

Abstract

Nabilone is a modified cannabinol derivative with central nervous system activity. Administration of nabilone in single doses of 1 to 5 mg results in dose-related pharmacologic effects in man. One and 2.5 mg doses of nabilone induced relaxant and sedative effects in all subjects. No euphoria, dry mouth, tachycardia, or postural hypotension was seen after 1 mg, minimal effects were seen after 2.5 mg, and marked effects were seen after 5 mg. Effects were evident within 60 to 90 min and persisted for 8 to 12 hr. Nabilone produced no significant tachycardia. There were no changes in supine blood pressure; however, marked postural hypotension occurred after the 5-mg dose. The administration of nabilone at doses of 1 mg or 2 mg two times daily resulted in euphoria and dry mouth during the first two days of drug; thereafter tolerance developed to these effects but there was no apparent decrease in relaxation. Subjects challenged with a single 5-mg dose of nabilone showed a 66% reduction in symptoms and signs after the 7-day drug period compared to that of the same dose after 1 wk of placebo. Comparison of nabilone with other cannabinol derivatives suggests that some of the undesirable pharmacologic effects can be separated within the ...Continue Reading

Citations

Jan 1, 1980·Psychopharmacology·R M GlassM W Fischman
Apr 1, 1983·Medicinal Research Reviews·R K Razdan, J F Howes
Aug 1, 1981·Journal of Clinical Pharmacology·L F Fabre, D McLendon
Apr 1, 1983·Journal of Clinical Pharmacology·H GongB Calvarese
Aug 1, 1981·Journal of Clinical Pharmacology·R Mechoulam
Aug 1, 1981·Journal of Clinical Pharmacology·L H EinhornS D Williams
Jan 1, 1978·Drug Metabolism Reviews·L Lemberger, A Rubin
Apr 1, 1987·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H R SullivanP G Wood
Aug 1, 1981·Journal of Clinical Pharmacology·R M GlassM W Fischman
Mar 15, 2006·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·David M BerlachMark A Ware
Jan 12, 2012·Clinical and Experimental Pharmacology & Physiology·Jarkko KalliomäkiMärta Segerdahl
Apr 1, 1978·Die Naturwissenschaften·R Mechoulam, E A Carlini
Jan 1, 1980·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R E BillingsR E McMahon
Aug 1, 1981·Journal of Clinical Pharmacology·N L Benowitz, R T Jones
Apr 21, 2010·Addiction·Mark A Ware, Emmanuelle St Arnaud-Trempe
Aug 1, 1981·Journal of Clinical Pharmacology·A K JainG Smith
Jan 1, 1988·Pharmacology & Therapeutics·R G Pertwee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved